Histone Demethylase Retinoblastoma Binding Protein 2 is Overexpressed in Hepatocellular Carcinoma and Negatively Regulated by hsa-miR-212

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Liang, Xiuming ^a   Zeng, Jiping ^a   Wang, Lixiang ^a   Fang, Ming ^a   Wang, Qing ^a   Zhao, Min ^a   Xu, Xia ^a   Liu, Zhifang ^a   Li, Wenjuan ^a   Liu, Shili ^a   Yu, Han ^a   Jia, Jihui ^a   Chen, Chunyan ^a,b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; HISTONE DEMETHYLASE; MICRORNA; MICRORNA 212; RETINOBLASTOMA BINDING PROTEIN 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA BINDING; SENESCENCE; UPREGULATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA-BINDING PROTEIN 2;

EID: 84880802542     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069784     Document Type: Article

References (44)

1. Yeh FS, Mo CC, Yen RC, (1985) Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China. Natl Cancer Inst Monogr 69: 47-48.
2. Long XD, Ma Y, Wei YP, Deng ZL, (2006) The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatology Research 36: 48-55.
3. Zhu Z, Jiang Y, Chen S, Jia S, Gao X, et al. (2011) An insertion/deletion polymorphism in the 3′ untranslated region of type I collagen a2 (COL1A2) is associated with susceptibility for hepatocellular carcinoma in a Chinese population. Cancer Genetics 204: 265-269.
4. He YM, Wang XY, Gao SD, Yu LY, Lin XD, et al. (2005) Ultrasound-guided fine needle biopsy of intrahepatic nodules and low elevation of AFP in early diagnosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 4: 50-54.
5. Forner A, Reig M, Bruix J, (2009) Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star. Gastroenterology 137: 26-29.
6. El-Serag HB, Kramer JR, Chen GJ, Duan Z, Richardson PA, et al. (2011) Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut 60: 992-997.
7. Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, et al. (2007) The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128: 1077-1088.
8. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, et al. (2007) The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128: 889-900.
9. Hayakawa T, Ohtani Y, Hayakawa N, Shinmyozu K, Saito M, et al. (2007) RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation. Genes Cells 12: 811-826.
10. Gutierrez GM, Kong E, Hinds PW, (2005) Master or slave: The complex relationship of RBP2 and pRb. Cancer cell 7: 501-502.
11. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG Jr, (2005) Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 18: 623-635.
12. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, et al. (2007) RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethylated Lysine 4 on Histone 3. Cell 128: 1063-1076.
13. Pasini D, Hansen KH, Christensen J, Agger K, Cloos PA, et al. (2008) Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev 22: 1345-1355.
14. Lopez-Bigas N, Kisiel TA, Dewaal DC, Holmes KB, Volkert TL, et al. (2008) Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol Cell 31: 520-530.
15. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, et al. (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141: 69-80.
16. Zeng J, Ge Z, Wang L, Li Q, Wang N, et al. (2010) The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology 138: 981-992.
17. Zhang Z, Li Z, Gao C, Chen P, Chen J, et al. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88: 1358-1366.
18. Jiang S, Zhang HW, Lu MH, He XH, Li Y, et al. (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127.
19. Wada R, Akiyama Y, Hashimoto Y, Fukamachi H, Yuasa Y, (2010) hsa-miR-212 is down-regulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J Cancer 127: 1106-1114.
20. Hatakeyama H, Cheng H, Wirth P, Counsell A, Marcrom SR, et al. (2010) Regulation of heparin-binding EGF-like growth factor by hsa-miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. PLoS One. 5: e12702.
21. Ju Y, Hou N, Meng J, Wang X, Zhang X, et al. (2010) T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 52(3): 322-329.
22. Liu H, Luan F, Ju Y, Shen H, Gao L, et al. (2007) In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase. Biochem Biophys Res Commun. 355(2): 379-384.
23. Yue X, Zhang Z, Liang X, Gao L, Zhang X, et al. (2012) Zinc Fingers and Homeoboxes 2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Represses Expression of Cyclins A and E. Gastroenterology. 142(7): 1559-1570.
24. Kauffman EC, Robinson BD, Downes MJ, Powell LG, Lee MM, et al. (2011) Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog. 50(12): 931-944.
25. Roesch A, Mueller AM, Stempfl T, Moehle C, Landthaler M, et al. (2008) RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int J Cancer. 122: 1047-1057.
26. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, et al. (2010) A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141: 583-594.
27. Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, et al. (2011) The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene 31(6): 776-786.
28. Tabernero MD, Espinosa AB, Maillo A, Rebelo O, Vera JF, et al. (2007) Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas. Oncologist. 12: 1225-1236.
29. Cochrane DR, Cittelly DM, Howe EN, Spoelstra NS, McKinsey EL, et al. (2010) MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer. Horm Cancer 1: 306-319.
30. Marcucci G, Mrózek K, Radmacher MD, Garzon R, Bloomfield CD, (2011) The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 117: 1121-1129.
31. Dykxhoorn DM, (2010) MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 70: 6401-6406.
32. Mongroo PS, Rustgi AK, (2010) The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther 10: 219-222.
33. Gong C, Yao Y, Wang Y, Liu B, Wu W, et al. (2011) Up-regulation of miR-21 mediates resistanc to trastuzumab therapy for breast cancer. J Biol Chem 286: 19127-19137.
34. Medina PP, Nolde M, Slack FJ, (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
35. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, et al. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci 105: 3903-3908.
36. Im HI, Hollander JA, Bali P, Kenny PJ, (2010) MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci 13: 1120-1127.
37. Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, et al. (2010) Striatal microRNA controls cocaine intake through CREB signaling. Nature 466: 197-202.
38. Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, et al. (2010) hsa-miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res 70: 3638-3646.
39. Magill ST, Cambronne XA, Luikart BW, Lioy DT, Leighton BH, et al. (2010) microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci 107: 20382-20387.
40. Xu L, Wang F, Xu XF, Mo WH, Xia YJ, et al. (2011) Down-regulation of hsa-miR-212 expression by DNA hypermethylation in human gastric cancer cells. Med Oncol. 28Suppl 1: S189-196.
41. Incoronato M, Urso L, Portela A, Laukkanen MO, Soini Y, et al. (2011) Epigenetic Regulation of miR-212 Expression in Lung Cancer. PLoS One 6(11): e27722.
42. Suzuki H, Takatsuka S, Akashi H, Yamamoto E, Nojima M, et al. (2011) Genome-wide profiling of chromatin signatures reveals epigenetic regulation of microRNA genes in colorectal cancer. Cancer Res 71: 5646-5658.
43. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K, (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39: 493-506.
44. Prazeres H, Torres J, Rodrigues F, Pinto M, Pastoriza MC, et al. (2011) Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene 30: 1302-1317.